Autoimmune Disease Therapeutics Market Growth, Size, Share, Trends, and Forecast 2028
Autoimmune Disease Therapeutics Market by Drug Class (Immunosuppressants, Anti-Inflammatory Drugs, Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, and Biologics), By Distribution Channel (Hospitals, Clinics, Drug Stores, and Independent Pharmacies), And By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028
Category: Healthcare Report Format : PDF
Pages: 266 Report Code: ZMR-2140
Published Date: Jul-2022 Status : Published
| Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 54.8 Billion | USD 113.48 Billion | 12.9% | 2021 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Autoimmune Disease Therapeutics Market, (2022 - 2028) (USD Billion)
- 2.2 Global Autoimmune Disease Therapeutics Market : snapshot
- Chapter 3. Global Autoimmune Disease Therapeutics Market - Industry Analysis
- 3.1 Autoimmune Disease Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The growing prevalence of several autoimmune disorders drives the global market growth.
- 3.3 Market Restraints
- 3.3.1. Lack of funding and high costs associated with treating the diseases may hamper the global market growth.
- 3.4 Market Opportunities
- 3.4.1. Improvements in healthcare infrastructure and technology bring up several growth opportunities.
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Class
- 3.7.2 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Autoimmune Disease Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Autoimmune Disease Therapeutics Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Autoimmune Disease Therapeutics Market - Drug Class Analysis
- 5.1 Global Autoimmune Disease Therapeutics Market overview: By Drug Class
- 5.1.1 Global Autoimmune Disease Therapeutics Market share, By Drug Class, 2021 and 2028
- 5.2 Immunosuppressants
- 5.2.1 Global Autoimmune Disease Therapeutics Market by Immunosuppressants, 2022 - 2028 (USD Billion)
- 5.3 Anti-Inflammatory Drugs
- 5.3.1 Global Autoimmune Disease Therapeutics Market by Anti-Inflammatory Drugs, 2022 - 2028 (USD Billion)
- 5.4 Corticosteroids
- 5.4.1 Global Autoimmune Disease Therapeutics Market by Corticosteroids, 2022 - 2028 (USD Billion)
- 5.5 Nonsteroidal Anti-Inflammatory Drugs
- 5.5.1 Global Autoimmune Disease Therapeutics Market by Nonsteroidal Anti-Inflammatory Drugs, 2022 - 2028 (USD Billion)
- 5.6 Biologics
- 5.6.1 Global Autoimmune Disease Therapeutics Market by Biologics, 2022 - 2028 (USD Billion)
- 5.1 Global Autoimmune Disease Therapeutics Market overview: By Drug Class
- Chapter 6. Global Autoimmune Disease Therapeutics Market - Distribution Channel Analysis
- 6.1 Global Autoimmune Disease Therapeutics Market overview: By Distribution Channel
- 6.1.1 Global Autoimmune Disease Therapeutics Market share, By Distribution Channel, 2021 and 2028
- 6.2 Hospitals
- 6.2.1 Global Autoimmune Disease Therapeutics Market by Hospitals, 2022 - 2028 (USD Billion)
- 6.3 Clinics
- 6.3.1 Global Autoimmune Disease Therapeutics Market by Clinics, 2022 - 2028 (USD Billion)
- 6.4 Drug Stores
- 6.4.1 Global Autoimmune Disease Therapeutics Market by Drug Stores, 2022 - 2028 (USD Billion)
- 6.5 Independent Pharmacies
- 6.5.1 Global Autoimmune Disease Therapeutics Market by Independent Pharmacies, 2022 - 2028 (USD Billion)
- 6.1 Global Autoimmune Disease Therapeutics Market overview: By Distribution Channel
- Chapter 7. Autoimmune Disease Therapeutics Market - Regional Analysis
- 7.1 Global Autoimmune Disease Therapeutics Market Regional Overview
- 7.2 Global Autoimmune Disease Therapeutics Market Share, by Region, 2021 & 2028 (USD Billion)
- 7.3. North America
- 7.3.1 North America Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.3.1.1 North America Autoimmune Disease Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.3.1 North America Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 North America Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028
- 7.4.1 North America Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
- 7.5 North America Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028
- 7.5.1 North America Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4.2.1 Europe Autoimmune Disease Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.4.2 Europe Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 Europe Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028
- 7.4.1 Europe Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
- 7.5 Europe Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028
- 7.5.1 Europe Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.5.3.1 Asia Pacific Autoimmune Disease Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.5.3 Asia Pacific Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 Asia Pacific Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028
- 7.4.1 Asia Pacific Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
- 7.5 Asia Pacific Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028
- 7.5.1 Asia Pacific Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.6.4.1 Latin America Autoimmune Disease Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.6.4 Latin America Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 Latin America Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028
- 7.4.1 Latin America Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
- 7.5 Latin America Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028
- 7.5.1 Latin America Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Autoimmune Disease Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.7.5 The Middle-East and Africa Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 The Middle-East and Africa Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028
- 7.4.1 The Middle-East and Africa Autoimmune Disease Therapeutics Market, by Drug Class, 2022 - 2028 (USD Billion)
- 7.5 The Middle-East and Africa Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028
- 7.5.1 The Middle-East and Africa Autoimmune Disease Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Chugai Pharmaceutical Co. Ltd
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Amgen Inc
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Eli Lilly and Company
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Genentech Inc
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Elan Corporation Plc
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 F. Hoffmann-La Roche AG
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Squibb Company
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Merck & Co. Inc
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 GlaxoSmithKline Plc
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Bayer Schering Pharma AG
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Biogen Idec Inc
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Johnson & Johnson Inc
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Abbott Laboratories.
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.1 Chugai Pharmaceutical Co. Ltd
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Autoimmune Disease Therapeutics Market attractiveness, By Drug Class
- 6. Global Autoimmune Disease Therapeutics Market attractiveness, By Distribution Channel
- 7. Global Autoimmune Disease Therapeutics Market share by Drug Class, 2022 and 2028 (USD Billion)
- 8. Global Autoimmune Disease Therapeutics Market by Immunosuppressants, 2022 - 2028 (USD Billion)
- 9. Global Autoimmune Disease Therapeutics Market by Anti-Inflammatory Drugs, 2022 - 2028 (USD Billion)
- 10. Global Autoimmune Disease Therapeutics Market by Corticosteroids, 2022 - 2028 (USD Billion)
- 11. Global Autoimmune Disease Therapeutics Market by Nonsteroidal Anti-Inflammatory Drugs, 2022 - 2028 (USD Billion)
- 12. Global Autoimmune Disease Therapeutics Market by Biologics, 2022 - 2028 (USD Billion)
- 13. Global Autoimmune Disease Therapeutics Market share by Distribution Channel, 2022 and 2028 (USD Billion)
- 14. Global Autoimmune Disease Therapeutics Market by Hospitals, 2022 - 2028 (USD Billion)
- 15. Global Autoimmune Disease Therapeutics Market by Clinics, 2022 - 2028 (USD Billion)
- 16. Global Autoimmune Disease Therapeutics Market by Drug Stores, 2022 - 2028 (USD Billion)
- 17. Global Autoimmune Disease Therapeutics Market by Independent Pharmacies, 2022 - 2028 (USD Billion)
- 18. Global Autoimmune Disease Therapeutics Market share, by Region, 2022 and 2028
- 19. North America Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 20. Europe Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 21. Asia Pacific Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 22. Latin America Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
- 23. The Middle-East and Africa Autoimmune Disease Therapeutics Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global Autoimmune Disease Therapeutics Market: Snapshot
- 2. Drivers of the Autoimmune Disease Therapeutics Market: impact analysis
- 3. North America Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 4. North America Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 5. U.S. Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 6. U.S. Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 7. Canada Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 8. Canada Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 9. Europe Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 10. Europe Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 11. Germany Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 12. Germany Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 13. France Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 14. France Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 15. U.K. Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 16. U.K. Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 17. Italy Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 18. Italy Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 19. Spain Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 20. Spain Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 21. Rest of Europe Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 22. Rest of Europe Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 23. Asia Pacific Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 24. Asia Pacific Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 25. China Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 26. China Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 27. Japan Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 28. Japan Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 29. India Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 30. India Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 31. South Korea Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 32. South Korea Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 33. South-East Asia Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 34. South-East Asia Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 35. Rest of Asia Pacific Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 36. Rest of Asia Pacific Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 37. Latin America Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 38. Latin America Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 39. Brazil Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 40. Brazil Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 41. Mexico Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 42. Mexico Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 43. Rest of Latin America Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 44. Rest of Latin America Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 45. The Middle-East and Africa Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 46. The Middle-East and Africa Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 47. GCC Countries Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 48. GCC Countries Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 49. South Africa Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 50. South Africa Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
- 51. Rest of Middle-East Africa Autoimmune Disease Therapeutics Market revenue, By Drug Class, 2022 - 2028 (USD Billion)
- 52. Rest of Middle-East Africa Autoimmune Disease Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
Factors contributing to the global autoimmune disease therapy market's growth include rising autoimmune disease prevalence, more patient awareness, and increased laboratory automation, which allows for the simultaneous diagnosis of several diagnostic tests, resulting in faster and more accurate results. The prevalence of these disorders is increasing, which boosts consumer awareness of the therapeutics market.
According to the Zion Market Research report, the global autoimmune disease therapeutics market was worth about 54.8 (USD billion) in 2021 and is predicted to grow to around 113.48 (USD billion) by 2028, with a compound annual growth rate (CAGR) of about 12.9%.
North America dominates the autoimmune disease therapeutics market and accounts for more than 42.4% of the global revenue. This is due to the rising prevalence of autoimmune illnesses and the increased prominence of government initiatives. Increasing healthcare expenditure, improved healthcare infrastructure, increased adoption of new technologies, and the presence of significant vital players are all contributing to the region's market growth.
Some of the main competitors dominating the global autoimmune disease therapeutics market include - Chugai Pharmaceutical Co. Ltd, Amgen Inc, Eli Lilly and Company, Genentech Inc, Elan Corporation Plc, F. Hoffmann-La Roche AG, Squibb Company, Merck & Co. Inc, GlaxoSmithKline Plc, Bayer Schering Pharma AG, Biogen Idec Inc, Johnson & Johnson Inc, and Abbott Laboratories.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed